Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
Depression
Distress
Patient-reported outcomes
Supportive care
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
15
09
2019
accepted:
23
01
2020
pubmed:
27
2
2020
medline:
22
6
2021
entrez:
27
2
2020
Statut:
ppublish
Résumé
One of the most common psychological morbidities of cancer is depression. Routine depression symptoms screening (DSS) is recommended, but its ability to lead to psychosocial interventions in clinical practice is limited. We examined the use of and factors associated with psychosocial interventions for positive DSS following cancer diagnosis. We conducted a population-based cohort study of patients with diagnoses from 2010 to 2017 who reported ≥1 patient-reported Edmonton Symptom Assessment System (ESAS) score. Positive DSS was defined as ESAS ≥2 out of 10 for the depression item within 6 months of diagnosis. Outcomes were psychosocial interventions around the time of positive DSS: palliative care assessment, psychiatry/psychology assessment, social work referral, and antidepressant therapy (in patients ≥65 years of age with universal drug coverage). We examined reduction in depression symptom score (≥1 point) following intervention. Modified Poisson regression examined factors associated with interventions. Of 142,270 patients, 65,424 (46.0%) reported positive DSS at a median of 66 days (interquartile range: 34-105) after diagnosis. Of those with depression symptoms, 17.1% received palliative assessment, 1.7% psychiatry/psychology assessment, 8.4% social work referral, and 4.3% antidepressant therapy. Depression symptom score decreased in 67.2% who received palliative assessment, 63.7% with psychiatry/psychology assessment, 67.3% with social work referral, and 71.4% with antidepressant therapy. On multivariable analysis, patients with older age, rural residence, lowest income quintile, and genitourinary or oropharyngeal cancer were more likely to not receive intervention other than palliative care. The proportion of patients reporting positive DSS after cancer diagnosis receiving psychosocial intervention is low. We identified patients vulnerable to not receiving interventions, who may benefit from additional support. These data represent a call to action to modify practice and optimize the usefulness of systematic symptom screening. Patient-reported depression symptoms screening should be followed by targeted interventions to improve symptoms and patient-centered management.
Sections du résumé
BACKGROUND
One of the most common psychological morbidities of cancer is depression. Routine depression symptoms screening (DSS) is recommended, but its ability to lead to psychosocial interventions in clinical practice is limited. We examined the use of and factors associated with psychosocial interventions for positive DSS following cancer diagnosis.
MATERIALS AND METHODS
We conducted a population-based cohort study of patients with diagnoses from 2010 to 2017 who reported ≥1 patient-reported Edmonton Symptom Assessment System (ESAS) score. Positive DSS was defined as ESAS ≥2 out of 10 for the depression item within 6 months of diagnosis. Outcomes were psychosocial interventions around the time of positive DSS: palliative care assessment, psychiatry/psychology assessment, social work referral, and antidepressant therapy (in patients ≥65 years of age with universal drug coverage). We examined reduction in depression symptom score (≥1 point) following intervention. Modified Poisson regression examined factors associated with interventions.
RESULTS
Of 142,270 patients, 65,424 (46.0%) reported positive DSS at a median of 66 days (interquartile range: 34-105) after diagnosis. Of those with depression symptoms, 17.1% received palliative assessment, 1.7% psychiatry/psychology assessment, 8.4% social work referral, and 4.3% antidepressant therapy. Depression symptom score decreased in 67.2% who received palliative assessment, 63.7% with psychiatry/psychology assessment, 67.3% with social work referral, and 71.4% with antidepressant therapy. On multivariable analysis, patients with older age, rural residence, lowest income quintile, and genitourinary or oropharyngeal cancer were more likely to not receive intervention other than palliative care.
CONCLUSION
The proportion of patients reporting positive DSS after cancer diagnosis receiving psychosocial intervention is low. We identified patients vulnerable to not receiving interventions, who may benefit from additional support. These data represent a call to action to modify practice and optimize the usefulness of systematic symptom screening.
IMPLICATIONS FOR PRACTICE
Patient-reported depression symptoms screening should be followed by targeted interventions to improve symptoms and patient-centered management.
Identifiants
pubmed: 32100906
doi: 10.1634/theoncologist.2019-0709
pmc: PMC7356756
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1098-e1108Informations de copyright
© AlphaMed Press 2020.
Références
Gut. 2007 Dec;56(12):1770-98
pubmed: 17488783
J Pain Symptom Manage. 2016 Apr;51(4):662-672.e8
pubmed: 26743641
Psychooncology. 2011 Jun;20(6):572-84
pubmed: 21442689
Cancer. 2015 Sep 1;121(17):3027-35
pubmed: 26059846
N Engl J Med. 2017 Jan 12;376(2):105-108
pubmed: 28076708
Br J Cancer. 2004 Jun 14;90(12):2297-304
pubmed: 15162149
J Natl Cancer Inst. 2002 Apr 17;94(8):558-84
pubmed: 11959890
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Palliat Med. 2008 Mar;22(2):111-22
pubmed: 18372376
J Clin Oncol. 2012 Apr 1;30(10):1095-9
pubmed: 22370317
Psychooncology. 2007 Dec;16(12):1080-91
pubmed: 17464942
BMC Cancer. 2011 Feb 01;11:48
pubmed: 21284838
NCHS Data Brief. 2017 Aug;(283):1-8
pubmed: 29155679
N Engl J Med. 1999 Oct 28;341(18):1359-67
pubmed: 10536129
Psychooncology. 2014 Jun;23(6):601-12
pubmed: 24519814
Support Care Cancer. 2014 Jan;22(1):201-8
pubmed: 24026980
Med J Aust. 2016 May 16;204(9):348-50
pubmed: 27169968
J Natl Compr Canc Netw. 2010 Apr;8(4):362-6
pubmed: 20410331
Cancer. 2017 Nov 1;123(21):4286-4293
pubmed: 28782114
Ann Oncol. 2012 Aug;23(8):1973-1979
pubmed: 22473594
BMC Psychiatry. 2013 May 16;13:140
pubmed: 23679841
Ann Surg Oncol. 2018 Jun;25(6):1478-1487
pubmed: 29569126
Med Care. 1991 May;29(5):452-72
pubmed: 1902278
J Affect Disord. 2015 Mar 15;174:556-61
pubmed: 25556674
Health Rep. 1993;5(2):157-77
pubmed: 8292756
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
J Clin Epidemiol. 1988;41(5):495-501
pubmed: 3367181
J Clin Oncol. 2010 Nov 20;28(33):4884-91
pubmed: 20940193
J Natl Compr Canc Netw. 2007 Jan;5(1):3-7
pubmed: 17323529
BMC Health Serv Res. 2015 Jan 22;15:28
pubmed: 25608947
Health Serv Res. 2002 Oct;37(5):1345-64
pubmed: 12479500
J Clin Oncol. 2018 Apr 10;36(11):1103-1111
pubmed: 29494259
Psychiatr Serv. 2015 Jan 1;66(1):94-6
pubmed: 25322445
Psychooncology. 2006 May;15(5):398-406
pubmed: 16100708
Aust N Z J Psychiatry. 2000 Oct;34(5):785-91
pubmed: 11037364
Support Care Cancer. 2008 Mar;16(3):251-9
pubmed: 17602245
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
Curr Opin Support Palliat Care. 2009 Mar;3(1):55-60
pubmed: 19365162
Curr Oncol. 2019 Feb;26(1):e8-e16
pubmed: 30853804
Cancer. 2000 May 1;88(9):2164-71
pubmed: 10813730
J Psychosom Res. 2004 Sep;57(3):287-95
pubmed: 15507256
J Palliat Care. 1991 Summer;7(2):6-9
pubmed: 1714502
Br J Health Psychol. 2001 Nov;6(Part 4):347-360
pubmed: 12614509
J Clin Oncol. 1998 Apr;16(4):1594-600
pubmed: 9552071
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
Psychooncology. 2011 May;20(5):463-9
pubmed: 21456060
J Natl Compr Canc Netw. 2013 Feb 1;11(2):214-21
pubmed: 23411387
J Oncol Pract. 2016 Feb;12(2):172-4; e197-206
pubmed: 26787755
Psychooncology. 2010 Sep;19(9):923-32
pubmed: 19941285
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Oncologist. 2017 Jun;22(6):719-727
pubmed: 28438888
Med J Aust. 2010 Sep 6;193(S5):S58-61
pubmed: 21542448
Br J Cancer. 2001 Jan;84(2):179-85
pubmed: 11161373
J Clin Oncol. 2006 Jun 1;24(16):2420-7
pubmed: 16651649
J Oncol Pract. 2015 Mar;11(2):133-4
pubmed: 25515721
Acta Oncol. 2011 Feb;50(2):194-204
pubmed: 21231781
BMJ Support Palliat Care. 2011 Dec;1(3):301-5
pubmed: 24653474
Cancer. 2012 Dec 15;118(24):6260-9
pubmed: 22674666
Psychooncology. 2011 May;20(5):455-62
pubmed: 21456059
Eur J Pain. 2010 Jan;14(1):5-10
pubmed: 19264521
Patient Educ Couns. 2006 Dec;64(1-3):96-103
pubmed: 16427245
Psychooncology. 2013 Jan;22(1):168-76
pubmed: 21971977
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
Support Care Cancer. 2012 Nov;20(11):2795-802
pubmed: 22350596
Cancer. 2014 Oct 1;120(19):2946-54
pubmed: 24798107
J Natl Cancer Inst Monogr. 2004;(32):80-92
pubmed: 15263046
J Clin Oncol. 2008 Oct 10;26(29):4725-30
pubmed: 18695258
J Natl Cancer Inst. 2012 Jul 3;104(13):990-1004
pubmed: 22767203